Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

2.

The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system.

Sadeh R, Breitschopf K, Bercovich B, Zoabi M, Kravtsova-Ivantsiv Y, Kornitzer D, Schwartz A, Ciechanover A.

Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15690-5. doi: 10.1073/pnas.0808373105. Epub 2008 Oct 3.

3.

Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue.

Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A.

Oncogene. 2000 Nov 30;19(51):5944-50.

PMID:
11127826
4.

Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination.

Fajerman I, Schwartz AL, Ciechanover A.

Biochem Biophys Res Commun. 2004 Feb 6;314(2):505-12.

PMID:
14733935
6.

N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.

Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S.

Mol Cell Biol. 2004 Jul;24(14):6140-50.

7.
8.

N-terminal ubiquitination.

Ciechanover A.

Methods Mol Biol. 2005;301:255-70.

PMID:
15917637
10.

Approach for determining protein ubiquitination sites by MALDI-TOF mass spectrometry.

Wang D, Cotter RJ.

Anal Chem. 2005 Mar 1;77(5):1458-66.

PMID:
15732931
11.

Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.

Wang W, Nacusi L, Sheaff RJ, Liu X.

Biochemistry. 2005 Nov 8;44(44):14553-64.

PMID:
16262255
12.

Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11.

Hassink GC, Barel MT, Van Voorden SB, Kikkert M, Wiertz EJ.

J Biol Chem. 2006 Oct 6;281(40):30063-71. Epub 2006 Jul 29.

13.

Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.

Chen C, Zhou Z, Guo P, Dong JT.

FEBS Lett. 2007 Mar 20;581(6):1124-30. Epub 2007 Feb 16.

14.

The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology.

Ciechanover A.

Biol Chem Hoppe Seyler. 1994 Sep;375(9):565-81. Review.

PMID:
7840898
15.

Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.

Mansour M, Touka M, Malena A, Indiveri C, Dong W, Gionfriddo I, Accardi R, Paradiso A, Sylla BS, Gabet AS, Tommasino M.

Cancer Lett. 2007 Feb 8;246(1-2):274-81. Epub 2006 May 2.

PMID:
16650526
16.

Context of multiubiquitin chain attachment influences the rate of Sic1 degradation.

Petroski MD, Deshaies RJ.

Mol Cell. 2003 Jun;11(6):1435-44.

17.

The C-terminal domain of the Xenopus cyclin-dependent kinase inhibitor, p27Xic1, is both necessary and sufficient for phosphorylation-independent proteolysis.

Chuang LC, Zhu XN, Herrera CR, Tseng HM, Pfleger CM, Block K, Yew PR.

J Biol Chem. 2005 Oct 21;280(42):35290-8. Epub 2005 Aug 23.

18.

The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.

Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J, Schlegel R.

J Biol Chem. 2005 Mar 18;280(11):10807-16. Epub 2005 Jan 17.

19.

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

Matsumoto Y, Nakagawa S, Yano T, Takizawa S, Nagasaka K, Nakagawa K, Minaguchi T, Wada O, Ooishi H, Matsumoto K, Yasugi T, Kanda T, Huibregtse JM, Taketani Y.

J Med Virol. 2006 Apr;78(4):501-7.

PMID:
16482544
20.

Ubiquitination of, and sumoylation by, the Arf tumor suppressor.

den Besten W, Kuo ML, Tago K, Williams RT, Sherr CJ.

Isr Med Assoc J. 2006 Apr;8(4):249-51.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk